Satoshi Nojima

10PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMedical mycologyMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 10, 2025
Carbonic Anhydrase 12 as a Novel Prognostic Biomarker and Therapeutic Target for High-Risk Follicular Thyroid Carcinoma.

Masashi Tanida, Tsuyoshi Takashima, Shinichiro Tahara

|Jun 14, 2025
Psychiatric-onset neuronal intranuclear inclusion disease in a psychiatry-based dementia-enriched cohort in Japan.

Tesshin Miyamoto, Kohji Mori, Shoshin Akamine

|Feb 13, 2025
NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

Maiko Naito, Yoshito Takeda, Ryuya Edahiro

|May 19, 2023
Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8+ T cell cytotoxicity and proliferation.

Yujiro Naito, Shohei Koyama, Kentaro Masuhiro

|Feb 10, 2023
Ovarian high-grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance.

Kansuke Kido, Satoshi Nojima, Daisuke Motooka

|Sep 06, 2022
Class IV semaphorins in disease pathogenesis.

Satoshi Nojima

Pageof 2

Frequent Collaborators

4 joint publications

Shinichiro Tahara

3 joint publications

Kenji Ohshima

3 joint publications

Daisuke Okuzaki

2 joint publications

Eiichi Morii